Profile
| Metric | Value |
|---|---|
| Full Name | Quince Therapeutics, Inc. |
| Ticker | NASDAQ: QNCX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | quincetx.com |
| Employees | 36 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.27 | ||
| Price, 1D Change | -55.90% | |
| $15M | ||
| - | ||
| - | ||
| 0.14 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.31 | ||
| EPS, 1Y Change | -55.86% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | CRTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.31 | ||
| EPS Estimate | -$1.12 | |
| EPS Est. Change | +14.74% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $0.27 | ||
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +1,758.74% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.01 | -$0.84 | +72.00% | |
| -$1.17 | -$1.31 | -12.27% | |
| -$1.12 | N/A | +14.74% | |
| -$0.99 | N/A | +24.63% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -80.79% | ||
| -71.08% | ||
| -75.69% | ||
| -55.43% | ||
| 0.00% | ||
| 0.00% | ||
| -55.86% | ||
| +56.60% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.27 | ||
| $1.88 | ||
| SMA 200 vs Price | +598.33% | |
| $2.76 | ||
| SMA 50 vs Price | +926.73% | |
| 0.14 | ||
| $0.34 | ||
| 32.33 | ||
| 1,685.57% | ||
| 335.07% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.31 | ||
| -$186.00K | ||
| - | ||
| -$36.17M | ||
| - | ||
| -$56.83M | ||
| - | ||
| -$35.98M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.49 | ||
| 6.05 | ||
| 6.05 | ||
| - | ||
| - | ||
| -4.68 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 14.15 | ||
| -0.15 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $30.15M | ||
| $6.21M | ||
| $126.15M | ||
| $44.04M | ||
| $96.01M | ||
| $7.28M | ||
| $14.81M | ||
| $96.00K | ||
| $2.90M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $36.17M | ||
| $36.17M | ||
| $186.00K | ||
| $17.58M | ||
| $186.00K | ||
| $0.00 | ||
| $87.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$31.90M | ||
| $21.91M | ||
| -$4.78M | ||
| $257.00K | ||
| -$32.16M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| Citizens | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| JMP Securities | → | |
| JMP Securities | ||
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with QNCX
FAQ
What is the ticker symbol for Quince Therapeutics, Inc.?
The ticker symbol for Quince Therapeutics, Inc. is NASDAQ:QNCX
Does Quince Therapeutics, Inc. pay dividends?
No, Quince Therapeutics, Inc. does not pay dividends
What sector is Quince Therapeutics, Inc. in?
Quince Therapeutics, Inc. is in the Healthcare sector
What industry is Quince Therapeutics, Inc. in?
Quince Therapeutics, Inc. is in the Biotechnology industry
What country is Quince Therapeutics, Inc. based in?
Quince Therapeutics, Inc. is headquartered in United States
When did Quince Therapeutics, Inc. go public?
Quince Therapeutics, Inc. initial public offering (IPO) was on May 9, 2019
Is Quince Therapeutics, Inc. in the S&P 500?
No, Quince Therapeutics, Inc. is not included in the S&P 500 index
Is Quince Therapeutics, Inc. in the NASDAQ 100?
No, Quince Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Quince Therapeutics, Inc. in the Dow Jones?
No, Quince Therapeutics, Inc. is not included in the Dow Jones index
When was Quince Therapeutics, Inc. last earnings report?
Quince Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does Quince Therapeutics, Inc. report earnings?
The next expected earnings date for Quince Therapeutics, Inc. is March 23, 2026
Data Sources & References
- QNCX Official Website www.quincetx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1662774/000119312525277529/0001193125-25-277529-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1662774/000166277425000012/0001662774-25-000012-index.htm
- QNCX Profile on Yahoo Finance finance.yahoo.com/quote/QNCX
- QNCX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/qncx